Scientists have discovered a bacterial toxin that promotes tissue healing.

Scientists from the United States have found that a certain class of antibiotics could be promising for the treatment of frontotemporal dementia.

By using a new approach, scientists have developed an experimental vaccine against Toxoplasma gondii.

A study has shown that sequential administration of two different Ebola virus vaccines at regular intervals may provide the best immune response.

European Medicines Agency is considering the application of the American Bluebird Bio for the registration of cerebral adrenoleukodystrophy drug.

Department of the National Health Service of UK in association with the NHS Business Services Authority have developed RTEC based drug dispensing platform.

The FDA has approved the anticoagulant Brilinta for use in patients with cardiovascular disease.

In a small study, a biotech company has tested its own amyotrophic lateral sclerosis drug.

Scenic Biotech founders and biologists have designed their own functional genomics platform to accurately identify genes that modify a specific disease.

The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.